Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Two-year follow-up of the NEVO ResElution-I(NEVO RES-I) trial: a randomised, multicentre comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions.
Abizaid A, Ormiston JA, Fajadet J, Mauri L, Schofer J, Verheye S, Dens J, Thuesen L, Macours N, Qureshi AC, Spaulding C; NEVO ResElution-I Investigators. Abizaid A, et al. Among authors: verheye s. EuroIntervention. 2013 Oct;9(6):721-9. doi: 10.4244/EIJV9I6A116. EuroIntervention. 2013. PMID: 23518218 Free article.
The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES).
Serruys PW, Sianos G, Abizaid A, Aoki J, den Heijer P, Bonnier H, Smits P, McClean D, Verheye S, Belardi J, Condado J, Pieper M, Gambone L, Bressers M, Symons J, Sousa E, Litvack F. Serruys PW, et al. Among authors: verheye s. J Am Coll Cardiol. 2005 Jul 19;46(2):253-60. doi: 10.1016/j.jacc.2005.03.069. J Am Coll Cardiol. 2005. PMID: 16022951 Free article. Clinical Trial.
Analysis of bifurcation lesions treated with novel drug-eluting dedicated bifurcation stent system: intravascular ultrasound results of the AXXESS PLUS trial.
Miyazawa A, Ako J, Hassan A, Hasegawa T, Abizaid A, Verheye S, McClean D, Neumann FJ, Grube E, Honda Y, Fitzgerald PJ. Miyazawa A, et al. Among authors: verheye s. Catheter Cardiovasc Interv. 2007 Dec 1;70(7):952-7. doi: 10.1002/ccd.21269. Catheter Cardiovasc Interv. 2007. PMID: 18044777 Clinical Trial.
A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study.
Krucoff MW, Kereiakes DJ, Petersen JL, Mehran R, Hasselblad V, Lansky AJ, Fitzgerald PJ, Garg J, Turco MA, Simonton CA 3rd, Verheye S, Dubois CL, Gammon R, Batchelor WB, O'Shaughnessy CD, Hermiller JB Jr, Schofer J, Buchbinder M, Wijns W; COSTAR II Investigators Group. Krucoff MW, et al. Among authors: verheye s. J Am Coll Cardiol. 2008 Apr 22;51(16):1543-52. doi: 10.1016/j.jacc.2008.01.020. J Am Coll Cardiol. 2008. PMID: 18420096 Free article. Clinical Trial.
Analysis of left main coronary artery bifurcation lesions treated with biolimus-eluting DEVAX AXXESS plus nitinol self-expanding stent: intravascular ultrasound results of the AXXENT trial.
Hasegawa T, Ako J, Koo BK, Miyazawa A, Sakurai R, Chang H, Dens J, Verheye S, Grube E, Honda Y, Fitzgerald PJ. Hasegawa T, et al. Among authors: verheye s. Catheter Cardiovasc Interv. 2009 Jan 1;73(1):34-41. doi: 10.1002/ccd.21765. Catheter Cardiovasc Interv. 2009. PMID: 19089934 Clinical Trial.
9-month clinical, angiographic, and intravascular ultrasound results of a prospective evaluation of the Axxess self-expanding biolimus A9-eluting stent in coronary bifurcation lesions: the DIVERGE (Drug-Eluting Stent Intervention for Treating Side Branches Effectively) study.
Verheye S, Agostoni P, Dubois CL, Dens J, Ormiston J, Worthley S, Trauthen B, Hasegawa T, Koo BK, Fitzgerald PJ, Mehran R, Lansky AJ. Verheye S, et al. J Am Coll Cardiol. 2009 Mar 24;53(12):1031-9. doi: 10.1016/j.jacc.2008.12.012. J Am Coll Cardiol. 2009. PMID: 19298915 Free article. Clinical Trial.
First-in-man (FIM) study of the Stentys bifurcation stent--30 days results.
Verheye S, Grube E, Ramcharitar S, Schofer JJ, Witzenbichler B, Kovac J, Hauptmann KE, Agostoni P, Wiemer M, Lefèvre T, Serruys PW, van Geuns RJ. Verheye S, et al. EuroIntervention. 2009 Mar;4(5):566-71. doi: 10.4244/eijv4i5a96. EuroIntervention. 2009. PMID: 19378675 Clinical Trial.
Re-examining minimal luminal diameter relocation and quantitative coronary angiography--intravascular ultrasound correlations in stented saphenous vein grafts: methodological insights from the randomised RRISC trial.
Semeraro O, Agostoni P, Verheye S, Van Langenhove G, Van den Heuvel P, Convens C, Van den Branden F, Bruining N, Vermeersch P; Reduction of Restenosis in Saphenous Vein Grafts with Cypher Stent Trial Investigators. Semeraro O, et al. Among authors: verheye s. EuroIntervention. 2009 Mar;4(5):633-40. doi: 10.4244/eijv4i5a106. EuroIntervention. 2009. PMID: 19378685 Clinical Trial.
209 results